Business Description
Jiangsu Bioperfectus Technologies Co Ltd
ISIN : CNE1000055B2
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.36 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -1.9 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.81 | |||||
Beneish M-Score | -9.2 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -38.6 | |||||
3-Year Book Growth Rate | 26.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.7 | |||||
9-Day RSI | 44.05 | |||||
14-Day RSI | 42.99 | |||||
3-1 Month Momentum % | 9.13 | |||||
6-1 Month Momentum % | 23.6 | |||||
12-1 Month Momentum % | 59.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.19 | |||||
Quick Ratio | 4.96 | |||||
Cash Ratio | 4.69 | |||||
Days Inventory | 329.67 | |||||
Days Sales Outstanding | 104.83 | |||||
Days Payable | 140.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.95 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.75 | |||||
Operating Margin % | -17.57 | |||||
Net Margin % | -43.23 | |||||
FCF Margin % | 45.35 | |||||
ROE % | -4.97 | |||||
ROA % | -4.25 | |||||
ROIC % | -4.12 | |||||
3-Year ROIIC % | -134.69 | |||||
ROC (Joel Greenblatt) % | -23.25 | |||||
ROCE % | -4.8 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10.75 | |||||
PB Ratio | 1.25 | |||||
Price-to-Tangible-Book | 1.26 | |||||
Price-to-Free-Cash-Flow | 23.55 | |||||
Price-to-Operating-Cash-Flow | 16.16 | |||||
EV-to-EBIT | -13.78 | |||||
EV-to-EBITDA | -13.78 | |||||
EV-to-Revenue | 6 | |||||
EV-to-FCF | 13.4 | |||||
Price-to-GF-Value | 5.35 | |||||
Price-to-Projected-FCF | 0.61 | |||||
Price-to-Net-Current-Asset-Value | 2.37 | |||||
Price-to-Net-Cash | 2.72 | |||||
Earnings Yield (Greenblatt) % | -7.26 | |||||
FCF Yield % | 4.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Jiangsu Bioperfectus Technologies Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 394.835 | ||
EPS (TTM) (Â¥) | -2.92 | ||
Beta | 0.58 | ||
3-Year Sharpe Ratio | -0.79 | ||
3-Year Sortino Ratio | -0.94 | ||
Volatility % | 32 | ||
14-Day RSI | 42.99 | ||
14-Day ATR (Â¥) | 2.85013 | ||
20-Day SMA (Â¥) | 74.218 | ||
12-1 Month Momentum % | 59.88 | ||
52-Week Range (Â¥) | 49.02 - 105.15 | ||
Shares Outstanding (Mil) | 56.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jiangsu Bioperfectus Technologies Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jiangsu Bioperfectus Technologies Co Ltd Stock Events
Event | Date | Price (Â¥) | ||
---|---|---|---|---|
No Event Data |
Jiangsu Bioperfectus Technologies Co Ltd Frequently Asked Questions
What is Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399)'s stock price today?
When is next earnings date of Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399)?
Does Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |